(813) 971-8080

7210 Wareham Drive, Tampa, FL 33647

diet doctors

Eli Lilly Offers Weight Loss Drug Direct to Consumers

January 5, 2023 Eli Lilly and Company launched a website, lillydirect.com, to enable people to directly order from the drug maker including its weight-loss medicine Zepbound as well as connect people with obesity and other conditions with telehealth companies. The service, called LillyDirect, comes on the back on extraordinary demand seen over the last year

Eli Lilly Offers Weight Loss Drug Direct to Consumers Read More »

More Obesity Drugs in the Pipeline – Boehringer Ingelheim

August 20, 2023 Boehringer Ingelheim could soon stake a claim in the lucrative obesity treatment market after the pharma company said it has advanced a candidate into three Phase III trials following promising data. Servodutide, the company’s glucagon/glucagon-like peptide 1 (GLP-1) receptor dual agonist co-developed with Zeland Pharma, demonstrated up to 19% weight loss after

More Obesity Drugs in the Pipeline – Boehringer Ingelheim Read More »

Medifast Reports Q2 Results

Aug. 8, 2023 Second quarter 2023 revenue decreased 34.7% to $296.2 million from $453.3 million for the second quarter of 2022, primarily driven by a decrease in the number of active earning OPTAVIA Coaches and the decline in the productivity per active earning OPTAVIA Coach. The average revenue per active earning OPTAVIA Coach was $5,578, compared to $6,667 for the second quarter last year, a

Medifast Reports Q2 Results Read More »

Weight Loss Market Recovers to $75 Billion – New Marketdata Report

March 20, 2023 Marketdata LLC, Tampa, FL, has just released it 17th Edition of its best-selling market research report: “The U.S. Weight Loss & Diet Control Market”. At 427 pages, with 160 Tables & Charts and 34 in-depth diet company competitor profiles, this is the most comprehensive analysis anywhere of the market. Some findings… The

Weight Loss Market Recovers to $75 Billion – New Marketdata Report Read More »

Scroll to Top